Morgan Stanley’s Rockley Photonics Holdings Limited Warrants, each warrant exercisable for one ordinary share at an exercise price of $11.50 RKLY.WS Stock Holding History

Morgan Stanley’s Portfolio RKLY.WS Stock Details RKLY.WS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-4,466	Closed	-$94	–	7980
2022 Q4	$94	Hold	4,466	–	–	﹤0.01%	7705
2022 Q3	$0	Hold	4,466	–	–	﹤0.01%	8059
2022 Q2	$1K	Hold	4,466	–	–	﹤0.01%	7747
2022 Q1	$4K	Hold	4,466	–	–	﹤0.01%	7664
2021 Q4	$5K	Hold	4,466	–	–	﹤0.01%	7669
2021 Q3	$11K	Buy	+4,466	New	+$10K	﹤0.01%	7299

Morgan Stanley's RKLY.WS Position: Q1 2023 in Review

Morgan Stanley sold out of Rockley Photonics Holdings Limited Warrants, each warrant exercisable for one ordinary share at an exercise price of $11.50 (RKLY.WS) in Q1 2023, closing a stake of 4,466 shares — an estimated $94 sold.

Morgan Stanley first reported a position in RKLY.WS in Q3 2021 and held it in 6 quarters. The position peaked at $11K in Q3 2021. 0 funds tracked by Wall St. Rank hold RKLY.WS as of Q1 2023.

Morgan Stanley reported no remaining Rockley Photonics Holdings Limited Warrants, each warrant exercisable for one ordinary share at an exercise price of $11.50 position as of Q1 2023 after selling out during the quarter.
Morgan Stanley sold 4,466 Rockley Photonics Holdings Limited Warrants, each warrant exercisable for one ordinary share at an exercise price of $11.50 shares in Q1 2023, an estimated $94.
Morgan Stanley first reported a position in Rockley Photonics Holdings Limited Warrants, each warrant exercisable for one ordinary share at an exercise price of $11.50 in Q3 2021 and held it in 6 quarters.
Morgan Stanley's Rockley Photonics Holdings Limited Warrants, each warrant exercisable for one ordinary share at an exercise price of $11.50 position peaked at $11K in Q3 2021.
0 funds tracked by Wall St. Rank held Rockley Photonics Holdings Limited Warrants, each warrant exercisable for one ordinary share at an exercise price of $11.50 as of Q1 2023.

Based on Morgan Stanley's 13F filing for Q1 2023, filed 15 May 2023.